Gamma cyclodextrin

DB19173InvestigationalSmall molecule

Gamma cyclodextrin is under investigation in clinical trial NCT03931057 (The use of ADV6209 for Premedication in Pediatric Anesthesia).

Formula / weight: C₄₈H₈₀O₄₀ · 1297.128 g/mol (avg)
Also known as: .gamma.-cyclodextrin · Alfadex impurity b · Cavamax w8 · Cyclodextrin, gamma- · Cyclomaltooctaose
Code names: E-458 · INS-458 · INS NO.458

Resolves to

Compound

UNIIKZJ0BYZ5VACAS17465-86-0ChEMBLCHEMBL3182126ChEBI495056

Clinical / RWD

RxNorm1366989

Structure

InChIKeyGDSRMADSINPKSL-HSEONFRVSA-NSMILES

[H][C@@]12O[C@H](CO)[C@@]([H])(O[C@@]3([H])O[C@H](CO)[C@@]([H])(O[C@@]4([H])O[C@H](CO)[C@@]([H])(O[C@@]5([H])O[C@H](CO)[C@@]([H])(O[C@@]6([H])O[C@H](CO)[C@@]([H])(O[C@@]7([H])O[C@H](CO)[C@@]([H])(O[C@@]8([H])O[C@H](CO)[C@@]([H])(O[C@@]9([H])O[C@H](CO)[C@@]([H])(O1)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O

What you can answer from here — as of July 09, 2026

3Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which companies are running trials of Gamma cyclodextrin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account